Dong Qu

602 total citations
11 papers, 431 citations indexed

About

Dong Qu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Dong Qu has authored 11 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Dong Qu's work include Cancer Immunotherapy and Biomarkers (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Vascular Tumors and Angiosarcomas (1 paper). Dong Qu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Vascular Tumors and Angiosarcomas (1 paper). Dong Qu collaborates with scholars based in China, Netherlands and United States. Dong Qu's co-authors include Hongnan Mo, Jing Huang, Dawei Wu, Bo Lan, Xuelian Chen, Xingyuan Wang, Qing Yang, Binghe Xu, Hong‐Tu Zhang and Yuchen Jiao and has published in prestigious journals such as Cancer, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Dong Qu

9 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Qu China 7 316 176 172 69 47 11 431
Shivani Handa United States 10 271 0.9× 175 1.0× 108 0.6× 29 0.4× 27 0.6× 25 406
Yuanyu Qian China 9 330 1.0× 212 1.2× 151 0.9× 45 0.7× 92 2.0× 17 589
Taro Tanabe Japan 12 312 1.0× 137 0.8× 120 0.7× 117 1.7× 13 0.3× 25 478
Iman Imanirad United States 13 275 0.9× 92 0.5× 80 0.5× 90 1.3× 44 0.9× 42 398
Evin Büyükünal Türkiye 13 197 0.6× 103 0.6× 152 0.9× 70 1.0× 13 0.3× 37 406
Jwa Hoon Kim South Korea 11 182 0.6× 81 0.5× 112 0.7× 74 1.1× 23 0.5× 30 348
Neil B. Newman United States 10 220 0.7× 169 1.0× 110 0.6× 13 0.2× 19 0.4× 36 363
Masafumi Tanaka Japan 8 298 0.9× 140 0.8× 118 0.7× 131 1.9× 11 0.2× 31 421
Imelda Parker Ireland 12 120 0.4× 220 1.3× 148 0.9× 61 0.9× 18 0.4× 25 448
Keishi Okubo Japan 12 254 0.8× 126 0.7× 254 1.5× 28 0.4× 27 0.6× 37 502

Countries citing papers authored by Dong Qu

Since Specialization
Citations

This map shows the geographic impact of Dong Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Qu more than expected).

Fields of papers citing papers by Dong Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Qu. The network helps show where Dong Qu may publish in the future.

Co-authorship network of co-authors of Dong Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Qu. A scholar is included among the top collaborators of Dong Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Qu. Dong Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
3.
Qu, Dong, et al.. (2022). Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease. BMC Pediatrics. 22(1). 29–29. 6 indexed citations
4.
Chen, Xuelian, Hongnan Mo, Dawei Wu, et al.. (2019). Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210. Cancer Biology and Medicine. 16(1). 173–173. 46 indexed citations
5.
Huang, Jing, Binghe Xu, Hongnan Mo, et al.. (2018). Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma. Clinical Cancer Research. 24(6). 1296–1304. 149 indexed citations
6.
Mo, Hongnan, Jing Huang, Jiachen Xu, et al.. (2018). Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study. British Journal of Cancer. 119(5). 538–545. 122 indexed citations
7.
8.
Ni, Song, Yiming Zhu, Dong Qu, et al.. (2017). Morbidity and Functional Outcomes following Free Jejunal Flap Reconstruction for Head and Neck Cancer. ORL. 79(4). 212–221. 6 indexed citations
9.
Liu, Jianfang, et al.. (2017). Improving CT detection sensitivity for nodal metastases in oesophageal cancer with combination of smaller size and lymph node axial ratio. European Radiology. 28(1). 188–195. 40 indexed citations
10.
Sun, Yu, Linqing Zhao, Jie Deng, et al.. (2014). Effect of human rhinovirus infection in pediatric patients with influenza-like illness on the 2009 pandemic influenza A(H1N1) virus. Chinese Medical Journal. 127(9). 1656–1660. 5 indexed citations
11.
Li, Jianguo, et al.. (2011). [Acute kidney injury in critically ill children infected with influenza A virus (H1N1) and enterovirus 71].. PubMed. 49(11). 839–42. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026